Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Pharma Companies United By a Need for Common Data Models
Posted on October 18th, 2017 by Betsy Davis in Pharma R&D
There is nothing that pharmaceutical companies guard more fiercely than their intellectual property. Devising and patenting the next big wonder drug is every company’s dream (more…)
Big Data and Proactive Pharmacovigilance
Posted on September 20th, 2017 by Christy J. Wilson in Pharmacovigilance
Traditionally thought of as a post-market process, pharmacovigilance is how pharmaceutical companies monitor and address any safety issues that arise once a drug becomes available commercially. However, some companies are now thinking ahead about these potential safety concerns with what is known as “proactive PV”. (more…)
Taking a Balanced Approach to Monitoring Literature
Posted on September 11th, 2017 by Neal Katz in Pharmacovigilance
In a time when the focus on pharmacovigilance is greater than ever before, literature monitoring presents pharmaceutical companies with significant challenges. Pharmacovigilance groups are looking for ways to efficiently and cost-effectively manage an increasing workload while remaining compliant with regulatory best practices. (more…)
What Are Best Practices in Literature Monitoring for Top-performing Pharma Companies?
Posted on June 14th, 2017 by Betsy Davis in Pharmacovigilance
The health and safety of patients is of utmost concern to pharmaceutical companies, and strict regulatory requirements ensure that safety standards remain high. But pharmacovigilance becomes an ever more difficult and overwhelming practice (more…)
